Somatostatin receptor sst1–sst5 expression in normal and neoplastic human tissues using receptor autoradiography with subtype-selective ligands
Countries where authors are citing Somatostatin receptor sst1–sst5 expression in normal and neoplastic human tissues using receptor autoradiography with subtype-selective ligands
This map shows the geographic impact of Somatostatin receptor sst1–sst5 expression in normal and neoplastic human tissues using receptor autoradiography with subtype-selective ligands. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Somatostatin receptor sst1–sst5 expression in normal and neoplastic human tissues using receptor autoradiography with subtype-selective ligands with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Somatostatin receptor sst1–sst5 expression in normal and neoplastic human tissues using receptor autoradiography with subtype-selective ligands more than expected).
Fields of papers citing Somatostatin receptor sst1–sst5 expression in normal and neoplastic human tissues using receptor autoradiography with subtype-selective ligands
This network shows the impact of Somatostatin receptor sst1–sst5 expression in normal and neoplastic human tissues using receptor autoradiography with subtype-selective ligands. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the Somatostatin receptor sst1–sst5 expression in normal and neoplastic human tissues using receptor autoradiography with subtype-selective ligands.
About Somatostatin receptor sst1–sst5 expression in normal and neoplastic human tissues using receptor autoradiography with subtype-selective ligands
This paper, published in 2001, received 517 indexed citations . Written by Jean Claude Reubi, Beatrice Waser, Jean‐Claude Schaer and Jean A. Laissue covering the research area of Epidemiology, Neurology and Oncology. It is primarily cited by scholars working on Epidemiology (415 citations), Oncology (280 citations) and Neurology (226 citations). Published in European Journal of Nuclear Medicine and Molecular Imaging.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
This paper is also available at doi.org/10.1007/s002590100541.